Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Net Cash Flow (2024 - 2025)

Historic Net Cash Flow for Neuphoria Therapeutics (NEUP) over the last 2 years, with Q4 2025 value amounting to $8.2 million.

  • Neuphoria Therapeutics' Net Cash Flow rose 33725.18% to $8.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $17.4 million, marking a year-over-year increase of 31455.89%. This contributed to the annual value of $1.6 million for FY2025, which is 28042.32% up from last year.
  • Per Neuphoria Therapeutics' latest filing, its Net Cash Flow stood at $8.2 million for Q4 2025, which was up 33725.18% from -$546385.0 recorded in Q3 2025.
  • Neuphoria Therapeutics' Net Cash Flow's 5-year high stood at $12.7 million during Q1 2025, with a 5-year trough of -$4.7 million in Q3 2024.